Brainstorm NS Treatments/Exposure

Co-Moderator(s)

• ID

  Ian Douglas, PhD

  Professor
  London School of Hygiene & Tropical Medicine, London, United Kingdom
• 

  Kristian Filion, PhD (he/him/his)

  Associate Professor
  McGill University
  Montreal, Canada

Presentations:

• 8:00 AM – 8:15 AM ADT

  Methotrexate and the Risk of Alzheimer’s Disease among U.S. Patients with Rheumatoid Arthritis
  

  Presenting Author: Caitlin N. Dodd, PhD (she/her/hers) – Panalgo
• 8:15 AM – 8:30 AM ADT

  Association between gabapentinoids and the risk of severe exacerbations in patients with chronic obstructive pulmonary disease
  

  Presenting Author: Alvi A. Rahman, MSc – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
• 8:30 AM – 8:45 AM ADT

  Comparative Safety of Alprazolam versus Other Benzodiazepines and Buspirone and Risk of Suicidal Behavior
  

  Presenting Author: Jill E. Lavigne, PhD (she/her/hers) – St John Fisher University/Department of Veteran Affairs
• 8:45 AM – 9:00 AM ADT

  Use of hypnotic-sedative medication and risk of falls and fractures in Danish adults: a self-controlled time-series study
  

  Presenting Author: Merete Osler, MD, DMSc, PhD – Center for Clincial Research and Prevention, Frederiksberg & Bispebjerg Hospitals
• 9:00 AM – 9:15 AM ADT

  Risk of Osteoporotic Fractures in Menopausal Women with Common Mental Health Problems Using SSRI/SNRI antidepressants: Cohort Study
  

  Presenting Author: Dana Alsugeir, Msc. PharmD. – University college london
• 9:15 AM – 9:30 AM ADT

  Risk of Opioid Overdose with Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors
  

  Presenting Author: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School